NCT01351688View on ClinicalTrials.gov

An Open Label Prostate Cancer Study in Japanese Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

May 31, 2013

Conditions
Prostate Cancer
Interventions
DRUG

AZD3514

Patients will be given AZD3514 tablets or capsules administered orally as a single dose, and then multiple once-daily dosing following a 7 day washout.

Trial Locations (2)

Unknown

Research Site, Sagamihara

Research Site, Sunto-gun

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY